[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  PRISM MarketView [@PrismMarketView](/creator/twitter/PrismMarketView) on x 4678 followers Created: 2025-07-19 13:16:57 UTC It was a big week for ophthalmology with new data, FDA updates, strategic shifts, and a secondary offering grabbing investor attention. Read the fill story: $ALDX $HROW $OKYO $VTRS $CLSD $RZLT  XXX engagements  **Related Topics** [$rzlt](/topic/$rzlt) [$clsd](/topic/$clsd) [$vtrs](/topic/$vtrs) [$okyo](/topic/$okyo) [$hrow](/topic/$hrow) [$aldx](/topic/$aldx) [investment](/topic/investment) [prism](/topic/prism) [Post Link](https://x.com/PrismMarketView/status/1946559888055767040)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
PRISM MarketView @PrismMarketView on x 4678 followers
Created: 2025-07-19 13:16:57 UTC
It was a big week for ophthalmology with new data, FDA updates, strategic shifts, and a secondary offering grabbing investor attention. Read the fill story: $ALDX $HROW $OKYO $VTRS $CLSD $RZLT
XXX engagements
Related Topics $rzlt $clsd $vtrs $okyo $hrow $aldx investment prism
/post/tweet::1946559888055767040